Table 1.

The identification results of saponins in the XST injection by LC/MSⁿ

Peak No.	Identification	Retention time (min)	MS[M-H]-	MS data (m/z)
1	Notoginsenoside R1	34.89	932	799 [M-H-Xyl]-; 637 [M-H-Xyl-Glc]-; 475 Agl
2	Ginsenoside Rg1	39.32	800	637 [M-H-Glc]-; 619 [M-H-H2O-Glc]-; 475 Agl
3	Ginsenoside Re	39.72	945	783 [M-H-Glc]-; 637 [M-H-Glc-Rha]-; 475 Agl
4	Notoginsenoside R4	51.24	1240	1107 [M-H-Xyl]-; 1077 [M-H-Glc]]-; 945 [M-H-Xyl-Glc; 783 [M-H-Xyl-2Glc]-
5	Ginsenoside Rf	51.89	800	637 [M-H-Glc]]-; 475 Agl
6	Notoginsenoside Fa	52.17	1240	1107 [M-H-Xyl]-; 1077 [M-H-Glc]]-; 945 [M-H-Xyl-Glc; 783 [M-H-Xyl-2Glc]-
7	Notoginsenoside I	52.39	1092	929[M-H-Glc]-; 767 [M-H-2Glc]-; 605[M-H-3Glc]-
8	SC1	52.56	901	769 [M-H-Xyl]-; 637 [M-H-2Xyl]-; 475 Agl
9	Ginsenoside Rb1	53.48	1107	945 [M-H-Glc]-; 783 [M-H-2Glc]-; 621 [M-H-3Glc]-; 459 Agl
10	Notoginsenoside Fc	54.32	1209	1077 [M-H-Xyl]-; 945 [M-H-2Xyl]-; 783 [M-H-2Xyl-Glc]-; 621 [M-H-2Xyl-2Glc]-; 459 Agl
11	Ginsenoside Rg2	54.75	783	637 [M-H-Rha]-; 621 [M-H-Glc]-; 475 Agl
12	Ginsenoside Rh1	55.04	637	475 [M-H-Glc]-
13	Ginsenoside Rb2	55.30	1077	945[M-H-Arap]-; 915[M-H-Glc]-; 783[M-HArap-Glc]-; 621[M-H-Arap-2Glc]-; 459 Agl
14	Ginsenoside F1	55.84	637	475 [M-H-Glc]-
15	Ginsenoside Rd	57.16	945	783 [M-H-Glc]-; 621[M-H-2Glc]-; 459Agl
16	Notoginsenoside K	58.32	945	783 [M-H-Glc]-; 621[M-H-2Glc]-; 459Agl
17	Notoginsenoside T5/Unkown	61.70	752	619[M-H-Xyl]-; 457 Agl
18	Unkown	62.09	765	603[M-H-Glc]-
19	Notoginsenoside T5/Unkown	62.42	752	619[M-H-Xyl]-; 457 Agl
20	Unkown	62.81	765	603[M-H-Glc]-
21	Ginsenoside Rk3	63.42	619	551 [M-H-C5H10]-
22	Ginsenoside Rh4	64.18	619	551 [M-H-C5H10]-
23	20(S)-ginsenoside Rg3	65.14	783	621 [M-H-Glc]-; 459 Agl
24	20(R)-ginsenoside Rg3	65.86	783	621 [M-H-Glc]-; 459 Agl
25	Ginsenoside F2	66.05	783	621 [M-H-Glc]-; 459 Agl
26	Ginsenoside Rk1	72.47	765	603[M-H-Glc]-
27	Ginsenoside Rg5	72.89	765	603[M-H-Glc]-